RAS Mutation Identifies a Poor Prognostic Molecular Subtype of Therapy-Related Myeloid Neoplasm
| dc.contributor.author | Kok, C.H. | |
| dc.contributor.author | Al-Kali, A. | |
| dc.contributor.author | Thomas, D. | |
| dc.contributor.author | He, R. | |
| dc.contributor.author | Kutyna, M.M. | |
| dc.contributor.author | Alkhateeb, H.B. | |
| dc.contributor.author | Lim, K. | |
| dc.contributor.author | Saliba, A.N. | |
| dc.contributor.author | Toop, C. | |
| dc.contributor.author | Matin, A. | |
| dc.contributor.author | Scott, H.S. | |
| dc.contributor.author | Gangat, N. | |
| dc.contributor.author | Brown, A.L. | |
| dc.contributor.author | Mangaonkar, A.A. | |
| dc.contributor.author | Hahn, C.N. | |
| dc.contributor.author | Begna, K. | |
| dc.contributor.author | Hung, K. | |
| dc.contributor.author | Greipp, P.T. | |
| dc.contributor.author | Hogan, W.J. | |
| dc.contributor.author | Patnaik, M.M. | |
| dc.contributor.author | et al. | |
| dc.date.issued | 2025 | |
| dc.description | Research Letter | |
| dc.description.abstract | Abstract not available. | |
| dc.description.statementofresponsibility | Chung Hoow Kok, Aref Al-Kali, Daniel Thomas, Rong He, Monika M. Kutyna, Hassan Alkhateeb, Kelly Lim, Antoine N. Saliba, Carla Toop, Aasiya Matin, Hamish Scott, Naseema Gangat, Anna Brown, Abhishek Mangaonkar, Christopher N. Hahn, Kebede Begna, Kevin Hung, Patricia Greipp, William J. Hogan, Mrinal Patnaik, Mithun Shah, and Devendra K. Hiwase | |
| dc.identifier.citation | Blood advances, 2025; 9(15):3814-3818 | |
| dc.identifier.doi | 10.1182/bloodadvances.2025016374 | |
| dc.identifier.issn | 2473-9529 | |
| dc.identifier.issn | 2473-9537 | |
| dc.identifier.orcid | Kok, C.H. [0000-0002-3181-7852] | |
| dc.identifier.orcid | Kutyna, M.M. [0000-0003-2315-091X] | |
| dc.identifier.orcid | Lim, K. [0000-0003-4606-7588] | |
| dc.identifier.orcid | Scott, H.S. [0000-0002-5813-631X] | |
| dc.identifier.orcid | Brown, A.L. [0000-0002-9023-0138] | |
| dc.identifier.orcid | Hahn, C.N. [0000-0001-5105-2554] | |
| dc.identifier.orcid | Hiwase, D.K. [0000-0002-6666-3056] | |
| dc.identifier.uri | https://hdl.handle.net/2440/147791 | |
| dc.language.iso | en | |
| dc.publisher | Elsevier | |
| dc.relation.grant | NHMRC | |
| dc.rights | © 2025 American Society of Hematology. Published by Elsevier Inc. Licensed under Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0), permitting only noncommercial, nonderivative use with attribution. All other rights reserved. | |
| dc.source.uri | https://doi.org/10.1182/bloodadvances.2025016374 | |
| dc.subject | RAS mutation; therapy-related myeloid neoplasm | |
| dc.title | RAS Mutation Identifies a Poor Prognostic Molecular Subtype of Therapy-Related Myeloid Neoplasm | |
| dc.type | Journal article | |
| pubs.publication-status | Published online |
Files
Original bundle
1 - 1 of 1
No Thumbnail Available
- Name:
- hdl_147791.pdf
- Size:
- 249.23 KB
- Format:
- Adobe Portable Document Format
- Description:
- Published version